» Articles » PMID: 24313162

Alcohol, DNA Methylation, and Cancer

Overview
Journal Alcohol Res
Specialty Psychiatry
Date 2013 Dec 10
PMID 24313162
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is one of the most significant diseases associated with chronic alcohol consumption, and chronic drinking is a strong risk factor for cancer, particularly of the upper aerodigestive tract, liver, colorectum, and breast. Several factors contribute to alcohol-induced cancer development (i.e., carcinogenesis), including the actions of acetaldehyde, the first and primary metabolite of ethanol, and oxidative stress. However, increasing evidence suggests that aberrant patterns of DNA methylation, an important epigenetic mechanism of transcriptional control, also could be part of the pathogenetic mechanisms that lead to alcohol-induced cancer development. The effects of alcohol on global and local DNA methylation patterns likely are mediated by its ability to interfere with the availability of the principal biological methyl donor, S-adenosylmethionine (SAMe), as well as pathways related to it. Several mechanisms may mediate the effects of alcohol on DNA methylation, including reduced folate levels and inhibition of key enzymes in one-carbon metabolism that ultimately lead to lower SAMe levels, as well as inhibition of activity and expression of enzymes involved in DNA methylation (i.e., DNA methyltransferases). Finally, variations (i.e., polymorphisms) of several genes involved in one-carbon metabolism also modulate the risk of alcohol-associated carcinogenesis.

Citing Articles

Alcohol Consumption and Breast and Ovarian Cancer Development: Molecular Pathways and Mechanisms.

Fanfarillo F, Caronti B, Lucarelli M, Francati S, Tarani L, Ceccanti M Curr Issues Mol Biol. 2024; 46(12):14438-14452.

PMID: 39727994 PMC: 11674816. DOI: 10.3390/cimb46120866.


Alcohol Consumption Does not Modify the Polygenic Risk Score-Based Genetic Risk of Breast Cancer in Postmenopausal Women: Atherosclerosis Risk in Communities Study.

Zhang M, Ru M, Zhang J, Wang Z, Lu J, Butler K Cancer Prev Res (Phila). 2024; 18(2):73-83.

PMID: 39676351 PMC: 11790378. DOI: 10.1158/1940-6207.CAPR-24-0208.


Expression pattern and prognostic significance of aldehyde dehydrogenase 2 in lung adenocarcinoma as a potential predictor of immunotherapy efficacy.

Baldari S, Antonini A, Di Rocco G, Toietta G Cancer Innov. 2024; 4(1):e149.

PMID: 39640071 PMC: 11620833. DOI: 10.1002/cai2.149.


Pre-diagnosis blood DNA methylation profiling of twin pairs discordant for breast cancer points to the importance of environmental risk factors.

Bode H, He L, Hjelmborg J, Kaprio J, Ollikainen M Clin Epigenetics. 2024; 16(1):160.

PMID: 39558433 PMC: 11574988. DOI: 10.1186/s13148-024-01767-y.


Genetics, diet, microbiota, and metabolome: partners in crime for colon carcinogenesis.

La Vecchia M, Sala G, Sculco M, Aspesi A, Dianzani I Clin Exp Med. 2024; 24(1):248.

PMID: 39470880 PMC: 11522171. DOI: 10.1007/s10238-024-01505-x.


References
1.
Rodriguez-Paredes M, Esteller M . Cancer epigenetics reaches mainstream oncology. Nat Med. 2011; 17(3):330-9. DOI: 10.1038/nm.2305. View

2.
Bonsch D, Lenz B, Fiszer R, Frieling H, Kornhuber J, Bleich S . Lowered DNA methyltransferase (DNMT-3b) mRNA expression is associated with genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm (Vienna). 2006; 113(9):1299-304. DOI: 10.1007/s00702-005-0413-2. View

3.
Halsted C, Robles E, Mezey E . Decreased jejunal uptake of labeled folic acid ( 3 H-PGA) in alcoholic patients: roles of alcohol and nutrition. N Engl J Med. 1971; 285(13):701-6. DOI: 10.1056/NEJM197109232851301. View

4.
Anantharaman D, Marron M, Lagiou P, Samoli E, Ahrens W, Pohlabeln H . Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer. Oral Oncol. 2011; 47(8):725-31. DOI: 10.1016/j.oraloncology.2011.05.004. View

5.
Bennett K, Lee W, Lamarre E, Zhang X, Seth R, Scharpf J . HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas. Genes Chromosomes Cancer. 2009; 49(4):319-26. DOI: 10.1002/gcc.20742. View